Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.52 |
| ▸ | THPO | P40225 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.47 |
| ▸ | FOLH1 | Q04609 | 5/20 | 0.47 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.47 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.47 |
| ▸ | GNPAT | O15228 | 1/20 | 0.43 |
| ▸ | ALB | P02768 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24978634 | 1.00 | MAPT (0.52) | MAPTSMN1; SMN2KDM4ETHRBALOX15 | |
| SCHEMBL24978671 | 1.00 | MAPT (0.52) | MAPTSMN1; SMN2KDM4ETHRBALOX15 | |
| SCHEMBL6445994 | 0.85 | KMT2A (0.53) | MAPTSMN1; SMN2KDM4ETHRBALOX15 | |
| SCHEMBL13226111 | 0.85 | MAPT (0.52) | MAPTSMN1; SMN2KDM4ETHRBALOX15 | |
| SCHEMBL15942692 | 0.85 | MAPT (0.52) | MAPTSMN1; SMN2KDM4ETHRBALOX15 | |
| SCHEMBL19100404 | 0.83 | KDM4E (0.50) | MAPTSMN1; SMN2KDM4ETHRBALOX15 | |
| SCHEMBL14478726 | 0.83 | NOD1 (0.54) | MAPTSMN1; SMN2KDM4ETHRBALOX15 | |
| SCHEMBL15451406 | 0.83 | NOD1 (0.54) | MAPTSMN1; SMN2KDM4ETHRBALOX15 | |
| SCHEMBL19718595 | 0.83 | FOLH1 (0.60) | MAPTSMN1; SMN2KDM4ETHRBALOX15 | |
| SCHEMBL15451421 | 0.83 | NOD1 (0.54) | MAPTSMN1; SMN2KDM4ETHRBALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025037775-A1 | COMPOSITION FOR PREVENTION, ALLEVIATION, OR TREATMENT OF DIABETES AND RELATED DISEASES | 주식회사 마이크로엑스 | 2025-02-20 | — | — | WO | disclosed |
| WO-2024147532-A1 | COMPOSITION FOR PREVENTION, ALLEVIATION, OR TREATMENT OF SEPSIS | 주식회사 마이크로엑스 | 2024-07-11 | — | — | WO | disclosed |
| WO-2023219227-A1 | COMPOSITION FOR PREVENTING, ALLEVIATING, OR TREATING ALZHEIMER'S DISEASE | 주식회사 마이크로엑스 | 2023-11-16 | — | — | WO | disclosed |
| US-20230026277-A1 | COMPOSITION FOR PREVENTION, ALLEVIATION, OR TREATMENT OF RESPIRATORY DISEASE | MICROX CO., LTD. (KR) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230026277-A1 | COMPOSITION FOR PREVENTION, ALLEVIATION, OR TREATMENT OF RESPIRATORY DISEASE | RELA, CSNK2A1, CSNK1G1 | MAPT 1943/4885SMN1; SMN2 3193/4885KDM4E 4088/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.